Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

510(k) Clearance Can Grease The Wheels For Firms Seeking China Market

This article was originally published in The Gray Sheet

  • News

Executive Summary

Approval time for device manufacturers aspiring to enter the China market can be cut in half if the product already is 510(k)-cleared, according to Bridgetech Holdings International CEO Michael Chermak

You may also be interested in...



China Should Not Be Overlooked By Smaller Device Firms, Consultant Says

Smaller device firms with technology commercialized in the U.S. or Europe should consider the supplemental revenue opportunity presented by China, says Synaptic Medical CEO Sophia Wang

China Should Not Be Overlooked By Smaller Device Firms, Consultant Says

Smaller device firms with technology commercialized in the U.S. or Europe should consider the supplemental revenue opportunity presented by China, says Synaptic Medical CEO Sophia Wang

China Product Registration, Test Protocol Reforms Targeted By AdvaMed

AdvaMed is drafting a case study on the regulation of pacemakers in China as a way to pinpoint potential hurdles for U.S. manufacturers

Table

View full table

Tags:
Latest Headlines

Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round

Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children

MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation

Second EU MDR Notified Body Designated In France

See All
UsernamePublicRestriction

Register

MT022507

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By